ELI LILLY AND CO. news, videos and press releases
For more news please use our advanced search feature.
ELI LILLY AND CO. - More news...
ELI LILLY AND CO. - More news...
- Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
- Eli Lilly and Company: Eli Lilly and Company Files 10-Q
- Eli Lilly and Company: Eli Lilly and Company Files 8-K
- Eli Lilly and Company: Eli Lilly and Company Files Form 4
- Eli Lilly and Company: Eli Lilly and Company Files 8-K
- Eli Lilly and Company: Eli Lilly and Company Files 10-Q
- Eli Lilly and Company: Eli Lilly and Company Files 8-K
- Eli Lilly and Company: ELI LILLY AND COMPANY FILES FORM 3, FORM 4, and FORM 5
- Eli Lilly and Company: Eli Lilly and Company calls company stockholders meeting
- Option-trading opportunities on Applied Materials, Inc., The Boeing Co., Jd.com Inc., Eli Lilly and Co., and NVIDIA Corp.
- Lilly Announces Preliminary Results of Elanco Exchange Offer
- Lilly to Participate in Barclays Global Healthcare Conference
- Lilly to Participate in Cowen Health Care Conference
- Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer
- Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults
- Lilly to Introduce Lower-Priced Insulin
- Lilly to Present Data Demonstrating Continued Scientific Advancements in Broad Dermatology Portfolio at AAD Annual Meeting
- Eli Lilly and Company: Eli Lilly and Company Files Preliminary Proxy
- Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing
- Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing
- Option-trading strategies on Freeport-McMoRan, Eli Lilly and Co., Riot Blockchain Inc., Twitter Inc. and Uniti Group Inc.
- Eli Lilly and Company: Eli Lilly and Company Files 10-K
- Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
- Lilly Completes Acquisition of Loxo Oncology
- Lilly To Participate in Leerink Partners Global Healthcare Conference
- Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride
- Option-trading strategies on Apple, Facebook, General Electric, Eli Lilly, and Vale
- Lilly to Participate in Guggenheim Healthcare Talks Idea Forum
- Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health
- Eli Lilly and Company: Eli Lilly and Company files 8-K
